Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt Praxis und Beruf Seltene Erkrankungen GOÄ & EBM
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Fachpsychotherapie Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende Patientenratgeber
Erweiterte Suche
Anmelden
nach oben
Journal of Natural Medicines
Erschienen in:

05.11.2024 | Note

3-Oxo-11αH-germacra-1(10) E,4Z-dien-12,6α-olide, a sesquiterpene from Artemisia sieversiana, attenuates lipopolysaccharide-induced inflammation via NF-κB/MAPK pathways and oxidative stress via ROS pathway in RAW264.7 cells

verfasst von: Qianqian Ren, Lili Wang, Xin Wang, Xiaoran Min, Xiling Dai, Guozheng Huang, Jianguo Cao

Erschienen in: Journal of Natural Medicines | Ausgabe 1/2025

Einloggen, um Zugang zu erhalten

Abstract

Inflammation is a vital and normal physiological response; however, excessive inflammation can contribute to the development of various diseases. Artemisia sieversiana, a traditional Chinese medicinal plant, contains a variety of chemical compounds. One such compound, 3-oxo-11αH-germacra-1(10)E,4Z-dien-12,6α-olide, a germacranolide sesquiterpenoid (germacranolide, GMO), has not been thoroughly investigated regarding its potential anti-inflammatory properties. In this study, the anti-inflammatory and antioxidant properties of GMO were investigated for the lipopolysaccharide (LPS)-induced inflammation in RAW264.7 cells. It was demonstrated that GMO effectively suppressed the production of inflammatory mediators, decreased the phosphorylation of nuclear factor kappa B (NF-κB) and mitogen-activated protein kinase (MAPK) in RAW264.7 cells. Additionally, GMO exhibited the capacity to mitigate oxidative damage induced by LPS, as indicated by assessments of reactive oxygen species and mitochondrial membrane potential. In summary, GMO possesses significant anti-inflammatory effects by modulating the NF-κB/MAPK pathway and antioxidant effects by regulating ROS production.

Graphical abstract

Literatur
1.
2.
Freire MO, Van Dyke TE (2013) Natural resolution of inflammation. Periodontol 2000(63):149–164CrossRef
3.
4.
5.
Zhang Q, Wang L, Wang S, Cheng H, Xu L, Pei G, Wang Y, Fu C, Jiang Y, He C, Wei Q (2022) Signaling pathways and targeted therapy for myocardial infarction. Signal Transduct Target Ther 7:78–116PubMedPubMedCentralCrossRef
6.
Yuan Q, Tang B, Zhang C (2022) Signaling pathways of chronic kidney diseases, implications for therapeutics. Signal Transduct Target Ther 7:182–209PubMedPubMedCentralCrossRef
7.
Chen Y, Fang ZM, Yi X, Wei X, Jiang DS (2023) The interaction between ferroptosis and inflammatory signaling pathways. Cell Death Dis 14:205–218PubMedPubMedCentralCrossRef
8.
9.
10.
11.
Zhou XD, Chen CX, Zheng XK, Gong LM, Zeng KW, Wang W, Tu PF (2021) Dibenzocyclooctadiene lignans from Artemisia sieversiana and their anti-inflammatory activities. J Nat Med 75:1014–1020PubMedCrossRef
12.
Suleimenov EM, Smagulova FM, Seidakhmetova RB, Aksartov RM, Raldugin VA, Adekenov SM (2007) 4-Epiashantin from Artemisia sieversiana. Chem Nat Compd 43:232–233CrossRef
13.
Liu SJ, Liao ZX, Liu C, Ji LJ, Sun H (2014) Two new sesquiterpenes from Artemisia sieversiana. Fitoterapia 97:43–49PubMedCrossRef
14.
Bohlmann F, Ang W, Trinks C, Jakupovic J, Huneck S (1985) Dimeric guaianolides from Artemisia sieversiana. Phytochemistry 24:1009–1015CrossRef
15.
Dong W, Huang XY, Li TZ, Weng YM, Geng CA, Chen JJ (2024) Artemsieverolactones A—H, eight guaiane-type sesquiterpenoid trimers from Artemisia sieversiana. Chin J Chem 42:1084–1092CrossRef
16.
Liu SJ, Liao ZX, Tang ZS, Cui CL, Liu HB, Liang YN, Zhang Y, Shi HX, Liu YR (2017) Phytochemicals and biological activities of Artemisia sieversiana. Phytochem Rev 16:441–460CrossRef
17.
Nuermaimaiti M, Turak A, Yang Q, Tang B, Zang Y, Li J, Aisa HA (2021) Sesquiterpenes from Artemisia Sieversiana and their anti-inflammatory activities. Fitoterapia 154:104996PubMedCrossRef
18.
Zhou XD, Chai XY, Zeng KW, Zhao MB, Jiang Y, Tu PF (2015) Artesin A, a new cage-shaped dimeric guaianolide from Artemisia sieversiana. Tetrahedron Lett 56:1141–1143CrossRef
19.
Cao Y, Feng YH, Gao LW, Li XY, Jin QX, Wang YY, Xu YY, Jin F, Lu SL, Wei MJ (2019) Artemisinin enhances the anti-tumor immune response in 4T1 breast cancer cells in vitro and in vivo. Int Immunopharmacol 70:110–116PubMedCrossRef
20.
Barrero AF, Quílez del Moral JF, Lara A, Herrador MM (2005) Antimicrobial activity of Sesquiterpenes from the essential oil of Juniperus thurifera Wood. Planta Med 71:67–71PubMedCrossRef
21.
Cheng XR, Zeng Q, Ren J, Qin JJ, Zhang SD, Shen YH, Zhu JX, Zhang F, Chang RJ, Zhu Y, Zhang WD, Jin HZ (2011) Sesquiterpene lactones from Inula falconeri, a plant endemic to the Himalayas, as potential anti-inflammatory agents. Eur J Med Chem 46:5408–5415PubMedCrossRef
22.
Liu L, Liu D, Xiang C, Dai W, Li B, Zhang M (2020) Sesquiterpene lactones from Artemisia austroyunnanensis suppresses ROS production and reduces cytokines, iNOS and COX-2 levels via NF-KB pathway in vitro. Nat Prod Res 34:1563–1566PubMedCrossRef
23.
Long J, Zhang SF, Wang PP, Zhang XM, Yang ZJ, Zhang Q, Chen Y (2014) Total syntheses of parthenolide and its analogues with macrocyclic stereocontrol. J Med Chem 57:7098–7112PubMedCrossRef
24.
Bai M, Chen JJ, Xu W, Dong SH, Liu QB, Lin B, Huang XX, Yao GD, Song SJ (2020) Elephantopinolide A-P, germacrane-type sesquiterpene lactones from Elephantopus scaber induce apoptosis, autophagy and G2/M phase arrest in hepatocellular carcinoma cells. Eur J Med Chem 198:112362PubMedCrossRef
25.
Freund RRA, Gobrecht P, Fischer D, Arndt HD (2020) Advances in chemistry and bioactivity of parthenolide. Nat Prod Rep 37:541–565PubMedCrossRef
26.
Xu H, Chen J, Chen P, Li W, Shao J, Hong S, Wang Y, Chen L, Luo W, Liang G (2023) Costunolide covalently targets NACHT domain of NLRP3 to inhibit inflammasome activation and alleviate NLRP3-driven inflammatory diseases. Acta Pharm Sin B 13:678–693PubMedCrossRef
27.
Tan RX, Lu H, Wolfender JL, Yu TT, Zheng WF, Yang L, Gafner S, Hostettmann K (1999) Mono- and sesquiterpenes and antifungal constituents from Artemisia species. Planta Med 65:64–67PubMedCrossRef
28.
Zhang X, Yang T, Jin X, Lin K, Dai X, Gao T, Huang G, Fan M, Ma L, Liu Z, Cao J (2022) Synthesis and biological evaluation of cytotoxic activity of novel podophyllotoxin derivatives incorporating piperazinyl-cinnamic amide moieties. Bioorg Chem 123:105761PubMedCrossRef
29.
Zhou M, Tang Y, Liao L, Liu M, Li Y (2021) Phillygenin inhibited LPS-induced RAW 264.7 cell inflammation by NF-κB pathway. Eur J Pharmacol 899:174043PubMedCrossRef
30.
Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR (1982) Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem 126:131–138PubMedCrossRef
31.
Hao H, Cao L, Jiang C, Che Y, Zhang S, Takahashi S, Wang G, Gonzalez FJ (2017) Farnesoid X receptor regulation of the NLRP3 inflammasome underlies cholestasis-associated sepsis. Cell Metab 25:856–867PubMedPubMedCentralCrossRef
32.
Zhu XJ, Shi Y, Peng J, Guo CS, Shan NN, Qin P, Ji XB, Hou M (2009) The effects of BAFF and BAFF-R-Fc fusion protein in immune thrombocytopenia. Blood 114:5362–5367PubMedCrossRef
33.
Pei X, Zhang Z, Wang N, Huang G, Min X, Yang Y, Cao J (2023) Onychiol B attenuates lipopolysaccharide-induced inflammation via MAPK/NF-κB pathways and acute lung injury in vivo. Bioorg Chem 132:106351PubMedCrossRef
34.
Lai JL, Liu YH, Liu C, Qi MP, Liu RN, Zhu XF, Zhou QG, Chen YY, Guo AZ, Hu CM (2017) Indirubin inhibits LPS-induced inflammation via TLR4 abrogation mediated by the NF-κB and MAPK signaling pathways. Inflammation 40:1–12PubMedCrossRef
35.
Burgos RA, Alarcón P, Quiroga J, Manosalva C, Hancke J (2020) Andrographolide, an anti-inflammatory multitarget drug: all roads lead to cellular metabolism. Molecules 26:5PubMedPubMedCentralCrossRef
36.
Mittal M, Siddiqui MR, Tran K, Reddy SP, Malik AB (2014) Reactive oxygen species in inflammation and tissue injury. Antioxid Redox Signal 20:1126–1167PubMedPubMedCentralCrossRef
37.
Kim EK, Choi EJ (2010) Pathological roles of MAPK signaling pathways in human diseases. Biochim Biophys Acta 1802:396–405PubMedCrossRef
38.
Dziarski R, Jin YP, Gupta D (1996) Differential activation of extracellular signal-regulated kinase (ERK) 1, ERK2, p38, and c-Jun NH2-terminal kinase mitogen-activated protein kinases by bacterial peptidoglycan. J Infect Dis 174:777–785PubMedCrossRef
39.
Oeckinghaus A, Hayden MS, Ghosh S (2011) Crosstalk in NF-κB signaling pathways. Nat Immunol 12:695–708PubMedCrossRef
40.
Tian X, Wang R, Gu T, Ma F, Laster KV, Li X, Liu K, Lee MH, Dong Z (2022) Costunolide is a dual inhibitor of MEK1 and AKT1/2 that overcomes osimertinib resistance in lung cancer. Mol Cancer 21:193–200PubMedPubMedCentralCrossRef
41.
Zhu S, Sun P, Bennett S, Charlesworth O, Tan R, Peng X, Gu Q, Kujan O, Xu J (2023) The therapeutic effect and mechanism of parthenolide in skeletal disease, cancers, and cytokine storm. Front Pharmacol 14:1111218PubMedPubMedCentralCrossRef
42.
Xi X, Liu N, Wang QQ, Chu YH, Yin Z, Ding YH, Lu YX (2019) ACT001, a novel PAI-1 inhibitor, exerts synergistic effects in combination with cisplatin by inhibiting PI3K/AKT pathway in glioma. Cell Death Dis 10:757–774PubMedPubMedCentralCrossRef
43.
Zhang Q, Lu Y, Ding Y, Zhai J, Ji Q, Ma W, Yang M, Fan H, Long J, Tong Z, Shi Y, Jia Y, Han B, Zhang W, Qiu C, Ma X, Li Q, Shi Q, Zhang H, Li D, Zhang J, Lin J, Li L-Y, Gao Y, Chen Y (2012) Guaianolide sesquiterpene lactones, a source to discover agents that selectively inhibit acute myelogenous leukemia stem and progenitor cells. J Med Chem 55:8757–8769PubMedCrossRef
44.
Luo H, Liu X, Liu H, Wang Y, Xu K, Li J, Liu M, Guo J, Qin X (2023) ACT001 ameliorates ionizing radiation-induced lung injury by inhibiting NLRP3 inflammasome pathway. Biomed Pharmacother 163:114808PubMedCrossRef
45.
Lu C, Li X, Du W, Zhang X, Li Y, Hu C, Mao Z, Zhang Y, Wang R (2024) Exploration of costunolide derivatives as potential anti-inflammatory agents for topical treatment of atopic dermatitis by inhibiting MAPK/NF-κB pathways. Bioorg Chem 143:107054PubMedCrossRef
46.
Nan L, Nam HH, Choo BK (2020) Costunolide inhibits inflammation in LPS-induced RAW264.7 cells and ameliorates gastric acid reflux-induced esophageal injury in rat model. Appl Biol Chem 63:33CrossRef
47.
Xie F, Zhang H, Zheng C, Shen XF (2020) Costunolide improved dextran sulfate sodium-induced acute ulcerative colitis in mice through NF-κB, STAT1/3, and Akt signaling pathways. Int Immunopharmacol 84:106567PubMedCrossRef
48.
49.
Shao JJ, Li WF, Sun JF, Zhuang ZS, Min JL, Long XH, Wu GJ, Xu HW, Liang G (2024) Britannin as a novel NLRP3 inhibitor, suppresses inflammasome activation in macrophages and alleviates NLRP3-related diseases in mice. Acta Pharmacol Sin 45:803–814PubMedCrossRef
50.
Jang YJ, Back MJ, Fu Z, Lee JH, Won JH, Ha HC, Lee HK, Jang JM, Choi JM, Kim DK (2016) Protective effect of sesquiterpene lactone parthenolide on LPS-induced acute lung injury. Arch Pharm Res 39:1716–1725PubMedCrossRef
51.
Linghu K, Cui W, Li T, Tuo Y, Wang D, Pan H, Zhang T, Lin L, Yu H, Hu X, Li H, Shen X (2024) Small molecule α-methylene-γ-butyrolactone, an evolutionarily conserved moiety in sesquiterpene lactones, ameliorates arthritic phenotype via interference DNA binding activity of NF-κB. Acta Pharm Sin B 14:3561–3575PubMedPubMedCentralCrossRef
Metadaten
Titel
3-Oxo-11αH-germacra-1(10) E,4Z-dien-12,6α-olide, a sesquiterpene from Artemisia sieversiana, attenuates lipopolysaccharide-induced inflammation via NF-κB/MAPK pathways and oxidative stress via ROS pathway in RAW264.7 cells
verfasst von
Qianqian Ren
Lili Wang
Xin Wang
Xiaoran Min
Xiling Dai
Guozheng Huang
Jianguo Cao
Publikationsdatum
05.11.2024
Verlag
Springer Nature Singapore
Erschienen in
Journal of Natural Medicines / Ausgabe 1/2025
Print ISSN: 1340-3443
Elektronische ISSN: 1861-0293
DOI
https://doi.org/10.1007/s11418-024-01854-7

Weitere Artikel der Ausgabe 1/2025

Aromatic polyketides isolated from the marine-derived fungus Didymella aeria and their neuroprotective activity

  • Note

Seven undescribed meroterpenoids from Sargassum siliquastrum and their inhibitory activity against amyloid β aggregation

  • Original Paper

Neuroprotective impact of glycitin on memory impairment in a pentylenetetrazol-induced chronic epileptic rat model: insights into hippocampal histology, oxidative stress, and inflammation

  • Original Paper

New sesquiterpenes from the soft coral Litophyton arboreum

  • Open Access
  • Note

Chemical profile and biological activities of Lysiphyllum binatum (Blanco) de Wit

  • Original Paper

Cathagines A–D, new bisindole alkaloids from Catharanthus roseus

  • Original Paper